Phase Genomics leverages its proprietary ultra-long-range sequencing technology in release of new RUO platform: the first high-resolution, low-cost solution to detect chromosome abnormalities Phase Genomics, Inc., a biotech company leading advancements in next-generation sequencing (NGS) solutions for genome assembly and analysis, today announced the launch of the beta version of its new platform for next […]
Will provide automated protein characterization, cell imaging and cell counting technologies, along with expertise and training WHAT: PerkinElmer, Inc. a global leader committed to innovating for a healthier world, today announced it is collaborating with leading life science incubators LabCentral in Boston, Massachusetts and MBC BioLabs in San Francisco, California to provide innovative, drug discovery technologies, expertise and training to help […]
Ragusa succeeds Hans Bishop, who will continue to serve as Advisor to the CEO through end of 2021 SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced that Bob Ragusa has been appointed as Chief Executive Officer of GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, effective immediately. GRAIL currently operates as […]
– Twist Bioscience to Offer Clinically Validated, Expert-Designed Exome Panel that Enriches Loci Relevant to Cancer, Rare and Inherited Diseases – SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an agreement with the Broad Institute for the distribution […]
With locations across the U.S., Kaycha Labs is establishing a national network of Cannabis and Hemp labs that provide essential product quality and safety information. FORT LAUDERDALE, Florida – Through its wholly owned affiliate, MH Verify, Kaycha Labs, a leader in Cannabis and Hemp testing technologies and methods, has launched a Hop Latent Viroid (HLVd) […]
Merck today announced the opening of its second Carlsbad, California-based facility, significantly expanding its global CDMO footprint. Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors Investment serves customers in addressing larger patient populations with new curative treatments Enables suspension production of viral vectors up to 1,000-liter scale […]
Move supports company’s multi-year strategic growth initiative; advances retention, attraction, and expansion of the team; enhances the ability to serve customers; and demonstrates Company’s commitment to the region DURHAM, N.C. – BioSkryb Genomics, Inc., today announced the relocation and expansion of its corporate headquarters and research center in Durham, N.C. to advance the growth and […]
SAN FRANCISCO — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Steffen Hellmold to the newly created position of senior vice president, business development, data storage. “We have made significant technological advances in our DNA data […]
Designed to accelerate the adoption of optical genome mapping (OGM) with the integration of BioDiscovery’s N x Clinical software solution for variant analysis Adds a world-class team, software and bioinformatics capabilities to address a broad range of applications in cancer and genetic diseases Brings potential for significant new growth opportunities in life science research and the clinical […]
SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ADC Development Panel, a specialized gene expression tool for use in the rapidly expanding field of Antibody Drug Conjugates (ADCs). Created in collaboration with leading pharmaceutical and clinical scientists, […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
